TP53 and neoplasm: Mutant p53 protein encoded by TP53 with MS mutations could inactivate p53‐related proteins and acquire new oncogenic functions (Freed‐Pastor & Prives, 2012), so the upregulation of TP53 helped the tumor cells evade apoptosis and senescence.